Inventor
Tatsuki Yokoseki
Inventor
Kanagawa, JP
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides29%
G01NInvestigating or analysing materials by determining their chemical or physical properties29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes13%
C12NMicroorganisms or enzymes4%
PatentTitleYear
11,079,386Monoclonal antibody against FZD10 and use thereof20219,090,680'Antibodies that specifically bind to abeta oligomers and uses thereof'20159,090,679'Antibodies that specifically bind to A beta oligomers and use thereof'20159,085,614'Antibodies that specifically bind to Aβ oligomers and uses thereof'20158,858,949'Antibodies that specifically bind to a beta oligomers and use thereof'20148,613,924'Antibodies that specifically bind to A beta oligomers and use thereof'20138,378,081'Antibodies that specifically bind to Aβ oligomers and uses thereof'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2015Patents assigned to IMMUNAS PHARMA INC (6)· patent assignee history
2013–2015Patents assigned to YOKOSEKI TATSUKI (5)· patent assignee history
2013–2015Patents assigned to FUJII SHINOBU (3)· patent assignee history
2013–2015Patents assigned to IMAI YUKIHO (3)· patent assignee history
2013–2015Patents assigned to ITO TOSHIYUKI (3)· patent assignee history
2013–2015Based in Kanagawa, JP· patent location history
2021Based in Kawasaki, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNAS PHARMA INC | 6 | 2013–2015 |
| YOKOSEKI TATSUKIself | 5 | 2013–2015 |
| FUJII SHINOBU | 3 | 2013–2015 |
| IMAI YUKIHO | 3 | 2013–2015 |
| ITO TOSHIYUKI | 3 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kanagawa, JP | 6 | 2013–2015 |
| Kawasaki, JP | 1 | 2021 |